This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The health secretary said he wants to automate and increase data collection thro...
In the first meeting of the CDC's Advisory Committee on Immunization Practices u...
As tariff threats and FDA staff cuts thrust the biopharma world into uncharted w...
Pharma companies are leveraging the Trump administration’s threat of tariffs on ...
GSK has been found guilty of bringing discredit on the pharma industry after a c...
After striking its February deal with Carlyle and SK Capital, bluebird said it r...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
The drug has hit several roadblocks in its European regulatory journey after its...
Camzyos came up short in a phase 3 trial weighing its use in patients with non-o...
After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuti...
Even as tariffs start to impact its medtech business, Johnson & Johnson is lifti...
Sanofi has said “deal” to Chrissy Teigen. The model, cookbook author and “Deal o...
Camzyos came up short in a phase 3 trial weighing its use in patients with non-o...
A two-day meeting of the Advisory Committee on Immunization Practices (ACIP), wh...
An investigation into the national security implications of pharma imports has b...
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet...
Amgen CEO Robert Bradway scored $24.4 million in total compensation last year, h...
Aurobindo's Aurolife Pharma has received a Form 483 from the FDA outlining 11 ob...
In a Friday speech to FDA employees, the HHS secretary laid bare his belief that...
Sandoz has filed an antitrust lawsuit in federal court in Virginia claiming that...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
If you ever find yourself doing outdoor hobbies in slow motion or bursting into ...
Despite President Donald Trump’s threat last week that tariffs on pharmaceutical...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...